Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
The Lancet. Oncology|September 18, 2016
Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre studySusan O'Brien, Jeffrey A Jones, Steven E Coutre, et al.
Atherosclerosis|February 7, 2018
A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)Meral Kayikcioglu, Lale Tokgozoglu, Mehmet Yilmaz, et al.
Journal of Clinical Lipidology|May 20, 2020
Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)Özlem Kuman Tunçel, Meral Kayıkçıoğlu, Şebnem Pırıldar, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 3, 2020
Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory MyelomaMeral Beksac, Yildiz Aydin, Hakan Goker, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 23, 2019
Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patientsOsman Ilhan, Zehra Narli Ozdemir, Gulsum Ozet, et al.
Clinical Laboratory|September 9, 2020
Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or CytopeniaZehra N Ozdemir, Osman Ilhan, Gulsum Ozet, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 12, 2023
The world apheresis association registry, 2023 updateHans Vrielink, Kaatje Le Poole, Bernd Stegmayr, et al.
International Journal of Hematologic Oncology|September 14, 2022
Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemiaGuray Saydam, Ali Unal, Ibrahim Celalettin Haznedaroglu, et al.
The Lancet. Infectious Diseases|August 11, 2019
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysisAlemnew F Dagnew, Osman Ilhan, Won-Sik Lee, et al.
American Journal of Blood Research|July 29, 2021
Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysisFatma Keklik Karadag, Mustafa Nuri Yenerel, Mehmet Yılmaz, et al.
Pageof 14